BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10989543)

  • 1. [Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis].
    Dhumeaux D; Hezode C
    Bull Acad Natl Med; 2000; 184(2):349-54. PubMed ID: 10989543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iron overload and cancer].
    Blanc JF; Bioulac-Sage P; Balabaud C
    Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic iron overload and hepatocellular carcinoma.
    Kew MC
    Cancer Lett; 2009 Dec; 286(1):38-43. PubMed ID: 19081672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle.
    Petrak J; Myslivcova D; Man P; Cmejla R; Cmejlova J; Vyoral D; Elleder M; Vulpe CD
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1490-8. PubMed ID: 17307722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.
    Fargion S; Valenti L; Fracanzani AL
    Dig Liver Dis; 2011 Feb; 43(2):89-95. PubMed ID: 20739232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
    Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
    Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics of hereditary iron overload].
    Le Gall JY; Jouanolle AM; Fergelot P; Mosser J; David V
    Bull Acad Natl Med; 2004; 188(2):247-62; discussion 262-3. PubMed ID: 15506716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantification of iron overload].
    Guyader D; Gandon Y
    Bull Acad Natl Med; 2000; 184(2):337-47; discussion 347-8. PubMed ID: 10989542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S65c frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload.
    Trombini P; Mauri V; Salvioni A; Corengia C; Arosio C; Piperno A
    Haematologica; 2001 Mar; 86(3):316-7. PubMed ID: 11255280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Iron overload and liver diseases].
    Huang CW; Bai L
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):370-1. PubMed ID: 12390751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iron and chronic liver disease (excluding genetic hemochromatosis and metabolic liver siderosis)].
    Hezode C; Dhumeaux D
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B82-7. PubMed ID: 10891769
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.
    Turlin B; Mendler MH; Moirand R; Guyader D; Guillygomarc'h A; Deugnier Y
    Am J Clin Pathol; 2001 Aug; 116(2):263-70. PubMed ID: 11488074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From iron accumulation to organ damage].
    Zaccone V; Gasbarrini G
    Minerva Med; 2012 Apr; 103(2):123-40. PubMed ID: 22513517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron and the liver.
    Corradini E; Ferrara F; Pietrangelo A
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():245-8. PubMed ID: 16462704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 3 hemochromatosis and beta-thalassemia trait.
    Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A
    Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.